Chugai Pharmaceutical stock: dividend
4519.TChugai Pharmaceutical paid $0.41 per share over the last twelve months, 0.92% on the price, and has not cut its dividend for at least 26 years.
Daily figure as of 13 Nov 2026
The amounts for the last 12 months and paid in fiscal 2025 differ if the company has raised or cut its dividend since then.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
All 11 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 29 Dec 2026 | 29 Dec 2026 | $0.4133 |
| 29 Jun 2026 | 28 Aug 2026 | $0.4133 |
| 29 Dec 2025 | 27 Mar 2026 | $0.9205 |
| 27 Jun 2025 | 28 Aug 2025 | $0.7827 |
| 27 Dec 2024 | 28 Mar 2025 | $0.3569 |
| 27 Jun 2024 | 29 Aug 2024 | $0.2567 |
| 28 Dec 2023 | 29 Mar 2024 | $0.2505 |
| 29 Jun 2023 | 30 Aug 2023 | $0.2505 |
| 29 Dec 2022 | 31 Mar 2023 | $0.2505 |
| 29 Jun 2022 | 30 Aug 2022 | $0.2380 |
| 29 Dec 2021 | 30 Mar 2022 | $0.2880 |
Is today's dividend yield unusually high?
Dividend yield today
0.92%
lower than in recent years$0.41 dividend per share over the last twelve months on a price of $44.97
Today 0.92%, on average over fiscal years 2016 to 2025 1.33% (range 0.95 to 2.50%). That is lower than in each of the last 10 fiscal years.
Since the end of fiscal 2025 on 31 Dec 2025, the dividend has fallen more than the price, so the yield has fallen.
- Fiscal year
- Today, last 12 months
For each fiscal year, the dividend per share for that year divided by the closing price on the last trading day of the fiscal year. The dashed line is the average (median) of the fiscal years.
Dividend development
Dividend per share
Payout ratio
- of earnings
- of free cash flow
Figures as a table
| Year | Dividend per share | Earnings per share |
|---|---|---|
| 2006 | $0.0703 | $0.14 |
| 2007 | $0.0692 | $0.15 |
| 2008 | $0.0689 | $0.15 |
| 2009 | $0.0752 | $0.22 |
| 2010 | $0.0835 | $0.16 |
| 2011 | $0.0897 | $0.14 |
| 2012 | $0.0835 | $0.18 |
| 2013 | $0.0877 | $0.20 |
| 2014 | $0.0939 | $0.20 |
| 2015 | $0.1085 | $0.23 |
| 2016 | $0.1211 | $0.20 |
| 2017 | $0.1148 | $0.28 |
| 2018 | $0.1335 | $0.35 |
| 2019 | $0.2150 | $0.60 |
| 2020 | $0.3484 | $0.82 |
| 2021 | $0.3757 | $1.15 |
| 2022 | $0.5262 | $1.43 |
| 2023 | $0.5009 | $1.24 |
| 2024 | $0.5070 | $1.47 |
| 2025 | $1.1393 | $1.65 |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 31 Jul 2019)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.